| Foreword (For First Edition) | 6 |
|---|
| Acknowledgements | 8 |
|---|
| Contents | 11 |
|---|
| Abbreviations | 18 |
|---|
| Chapter 1 | 21 |
|---|
| Brief History of Clinical Dialysis: The Seattle Experience | 21 |
| 1.1 Definition of Dialysis | 23 |
| 1.2 Mechanisms Involved in Molecular Movement | 23 |
| 1.2.1 Diffusion | 24 |
| 1.2.2 Ultrafiltration | 24 |
| 1.2.3 Osmosis | 25 |
| 1.2.4 Convection | 25 |
| 1.3 Clearance | 25 |
| 1.3.1 Blood vs Plasma Clearance | 26 |
| 1.3.2 Clinical Factors Influencing Dialysis Urea Clearance | 26 |
| Reference | 26 |
| Chapter 2 | 27 |
|---|
| Hemodialysis Technique | 27 |
| 2.1 Blood Flow Rate | 27 |
| 2.2 Dialysate Flow Rate | 27 |
| 2.3 Dialyzer Efficiency and Mass Transfer Area Coefficient (KoA) | 28 |
| 2.4 Different Hemodialysis Techniques | 28 |
| 2.4.1 Traditional Hemodialysis | 28 |
| 2.4.2 Hemofiltration | 29 |
| 2.4.3 Hemodiafiltration | 30 |
| 2.4.4 Slow Low Efficiency Dialysis (SLED) | 30 |
| 2.4.5 Ultrafiltration | 30 |
| 2.5 Hemodialysis Setup | 30 |
| 2.5.1 Blood Circuit | 31 |
| 2.5.1.1 Tubing Set | 31 |
| 2.5.1.2 Blood Pump | 32 |
| 2.5.1.3 Hemodialyzer | 33 |
| Dialyzer Characteristics | 34 |
| Reuse of Dialyzers | 38 |
| 2.5.2 Dialysate Circuit | 38 |
| 2.5.2.1 Dialysate | 38 |
| 2.5.2.2 Dialysate Delivery System | 40 |
| 2.5.2.3 DialysisWater | 43 |
| 2.5.2.4 Water Treatment System | 44 |
| References | 47 |
| Chapter 3 | 48 |
|---|
| Anticoagulation | 48 |
| 3.1 Heparin Anticoagulation | 49 |
| 3.1.1 Systemic Standard Heparinization | 50 |
| 3.1.2 Low-Dose Heparinization | 50 |
| 3.1.3 Low Molecular Weight Heparin | 50 |
| 3.2 Problems with Heparin Anticoagulation | 51 |
| 3.3 Alternatives to Heparin | 52 |
| 3.3.1 Citrate Anticoagulation | 52 |
| 3.3.1.1 Citrate Dialysate (Local Citrate) Anticoagulation | 52 |
| 3.3.1.2 Regional Citrate Anticoagulation | 53 |
| 3.3.1.3 Heparinoids | 53 |
| 3.3.1.4 Direct Thrombin Inhibitors | 54 |
| 3.3.1.5 Prostacyclin and other Prostanoids | 54 |
| 3.4 No Anticoagulation | 54 |
| References | 55 |
| Chapter 4 | 56 |
|---|
| Vascular Access | 56 |
| 4.1 Permanent Access | 56 |
| 4.1.1 Preparation | 56 |
| 4.1.1.1 Preferred Access Choice | 57 |
| 4.1.2 Arteriovenous Fistula | 57 |
| 4.1.2.1 Technique | 57 |
| 4.1.2.2 Fistula Use | 59 |
| 4.1.2.3 Arteriovenous Fistula Complications | 59 |
| 4.1.3 Arteriovenous Graft | 60 |
| 4.1.3.1 Graft Use | 61 |
| 4.1.3.2 Graft Complications | 61 |
| 4.1.4 Diagnosis and Management of Arteriovenous Dialysis Access | 62 |
| 4.1.4.1 Clinical Indicators of Problems with Grafts and Fistulae | 62 |
| 4.1.4.2 Diagnostic Tests | 63 |
| 4.1.4.3 Management | 64 |
| 4.1.5 Dual-Lumen Catheters with Dacron Cuff | 64 |
| 4.1.5.1 Complications | 65 |
| 4.1.6 Special Arteriovenous Shunts | 67 |
| 4.1.6.1 Scribner Shunt | 67 |
| 4.1.6.2 Thomas Shunt | 68 |
| 4.2 Temporary Access | 68 |
| 4.2.1 General Technique | 69 |
| 4.2.1.1 Internal Jugular Access | 69 |
| 4.2.1.2 Subclavian Access (Least Desirable) | 70 |
| 4.2.1.3 Femoral Access | 71 |
| 4.2.2 Complications of Temporary Access | 71 |
| 4.2.2.1 Procedure-Related Complications of Superior Vena Cava Access (Subclavian and Internal Jugular) | 73 |
| 4.2.2.2 Procedure-Related Complications of Femoral Vein Catheters | 73 |
| 4.2.2.3 Late Complications | 74 |
| 4.2.3 Comparison of the Three Access Sites | 74 |
| 4.3 Impact of Access | 74 |
| 4.3.1 Access Surveillance | 75 |
| References | 77 |
| Chapter 5 | 78 |
|---|
| Complications of Hemodialysis | 78 |
| 5.1 Medical Complications | 78 |
| 5.1.1 Hypotension | 78 |
| 5.1.1.1 Effect of Ultrafiltration | 79 |
| 5.1.1.2 Prevention of Hemodynamic Instability | 84 |
| 5.1.1.3 Clinical Manifestation of Hypotension | 85 |
| 5.1.1.4 Treatment of Hypotension | 85 |
| 5.1.1.5 Convective vs Diffusive Transport and Hypotension | 86 |
| 5.1.2 Cardiac Arrhythmias | 87 |
| 5.1.3 Intradialytic Hypertension | 88 |
| 5.1.4 Muscle Cramps | 88 |
| 5.1.4.1 Prevention | 89 |
| 5.1.4.2 Treatment | 89 |
| 5.1.5 Carnitine and Intradialytic Hypotension, Arrhythmias, and Muscle Cramps | 89 |
| 5.1.6 Nausea and Vomiting | 90 |
| 5.1.7 Headache | 90 |
| 5.1.8 Serious, Less Common Complications | 91 |
| 5.1.8.1 Dialysis Disequilibrium Syndrome | 91 |
| 5.1.8.2 Dialyzer-Related Reactions | 92 |
| 5.2 Machine-Related Complications | 94 |
| 5.2.1 Air Embolism | 94 |
| 5.2.1.1 Management | 94 |
| 5.2.2 Hemolysis | 95 |
| References | 95 |
| Chapter 6 | 97 |
|---|
| Dose of Hemodialysis | 97 |
| 6.1 Historical Background | 97 |
| 6.1.1 Dialysis Index | 98 |
| 6.1.2 Urea Clearance | 98 |
| 6.1.3 Urea as a Marker for Uremic Toxins | 99 |
| 6.1.4 Current Methods of Measuring Dialysis Dose | 99 |
| 6.1.4.1 Urea Reduction Ratio | 100 |
| 6.1.4.2 Calculating Kt/V from Urea Reduction | 100 |
| 6.1.4.3 Urea Kinetic Modeling | 101 |
| 6.2 Potential Problems with the Calculation of Dialysis Dose | 101 |
| 6.2.1 Influence of the Single-Pool Model | 101 |
| 6.2.1.1 Correcting for the Two-Pool Model | 103 |